128 related articles for article (PubMed ID: 26898755)
1. Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions.
Kumar A; Singhal M; Chopra C; Srinivasan S; Surabhi RP; Kanumuri R; Tentu S; Jagadeeshan S; Sundaram S; Ramanathan K; Shankar Pitani R; Muthuswamy B; Abhijit S; Nair AS; Venkatraman G; Rayala SK
Oncogene; 2016 Sep; 35(37):4857-65. PubMed ID: 26898755
[TBL] [Abstract][Full Text] [Related]
2. Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function.
Kanumuri R; Chelluboyina AK; Biswal J; Vignesh R; Pandian J; Venu A; Vaishnavi B; Leena DJ; Jeyaraman J; Ganesan K; Aradhyam GK; Venkatraman G; Rayala SK
Oncogene; 2021 Aug; 40(34):5327-5341. PubMed ID: 34253860
[TBL] [Abstract][Full Text] [Related]
3. UnPAKing RUNX3 functions-Both sides of the coin.
Kumar A; Sundaram S; Rayala SK; Venkatraman G
Small GTPases; 2019 Jul; 10(4):264-270. PubMed ID: 28628382
[TBL] [Abstract][Full Text] [Related]
4. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.
Goh YM; Cinghu S; Hong ETH; Lee YS; Kim JH; Jang JW; Li YH; Chi XZ; Lee KS; Wee H; Ito Y; Oh BC; Bae SC
J Biol Chem; 2010 Mar; 285(13):10122-10129. PubMed ID: 20100835
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.
Zhou WN; Du YF; Zheng Y; Zhang W; Wu YN; Song XM; Bai J
Mol Med Rep; 2019 Feb; 19(2):885-894. PubMed ID: 30535462
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
Chuang LS; Ito Y
Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm.
Cinghu S; Goh YM; Oh BC; Lee YS; Lee OJ; Devaraj H; Bae SC
J Cell Physiol; 2012 Mar; 227(3):1071-80. PubMed ID: 21567391
[TBL] [Abstract][Full Text] [Related]
9. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase.
Acconcia F; Barnes CJ; Singh RR; Talukder AH; Kumar R
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6782-7. PubMed ID: 17420447
[TBL] [Abstract][Full Text] [Related]
12. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
13. Runx3 in Immunity, Inflammation and Cancer.
Lotem J; Levanon D; Negreanu V; Bauer O; Hantisteanu S; Dicken J; Groner Y
Adv Exp Med Biol; 2017; 962():369-393. PubMed ID: 28299669
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Localization of RUNX3 via Histone Deacetylase-Mediated SRC Expression in Oxidative-Stressed Colon Cancer Cells.
Kang KA; Piao MJ; Ryu YS; Maeng YH; Hyun JW
J Cell Physiol; 2017 Jul; 232(7):1914-1921. PubMed ID: 27990641
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of RUNX3 in cancer metastasis (Review).
Chen F; Liu X; Bai J; Pei D; Zheng J
Oncol Rep; 2016 Mar; 35(3):1227-36. PubMed ID: 26708741
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
17. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells.
Peng Z; Tang H; Wang X; Zhou C; Fan J; Wang L; Jia Z; Li Q; Le X; Wei D; Xie K
Int J Oncol; 2008 Nov; 33(5):979-84. PubMed ID: 18949360
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.
Wang S; Liu H; Wang Z; Chen HX
Mol Med Rep; 2014 Apr; 9(4):1259-65. PubMed ID: 24535051
[TBL] [Abstract][Full Text] [Related]
20. Identification of RUNX3 as a component of the MST/Hpo signaling pathway.
Min B; Kim MK; Zhang JW; Kim J; Chung KC; Oh BC; Stein GS; Lee YH; van Wijnen AJ; Bae SC
J Cell Physiol; 2012 Feb; 227(2):839-49. PubMed ID: 21678419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]